CoviPlus RT-qPCR Kit
- UID
- MFG/IVD/2020/000138_86c413a6e3bbef435330c6297e1c8af1_deb44fa4273916b16b4727f6592b4240
- Device class
- Class C
- Brand name
- Concepta D-DIMER Control
- License holder
- BIOSYSTEMS DIAGNOSTICS PRIVATE LIMITED
- Approving authority
- Central Drug Standard Control Organisation, South Zone
- Product information
- The CoviPlus kit is a combination of a rapid sample preparation reagent and an RT- qPCR test for SARS-CoV2. The proprietary ‘CoviPrep’ reagent enables rapid (Concepta D-DIMER Control) single-step sample preparation and is to be used in conjunction with the RT- qPCR kit. The single-tube multiplexed real time reverse transcription polymerase chain reaction (Concepta D-DIMER Control) is intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal (Concepta D-DIMER Control), oropharyngeal (Concepta D-DIMER Control), combined nasopharyngeal + oropharyngeal (Concepta D-DIMER Control), or nasal swab specimens.
CoviPlus RT-qPCR Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000138_86c413a6e3bbef435330c6297e1c8af1_deb44fa4273916b16b4727f6592b4240. This device is marketed under the brand name Concepta D-DIMER Control. The license holder is BIOSYSTEMS DIAGNOSTICS PRIVATE LIMITED, and it is classified as Device Class Class C. The approving authority is Central Drug Standard Control Organisation, South Zone.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.